193 related articles for article (PubMed ID: 34603318)
1. IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant.
Bekele Y; Sui Y; Berzofsky JA
Front Immunol; 2021; 12():737406. PubMed ID: 34603318
[TBL] [Abstract][Full Text] [Related]
2. Chronic Immune Activation and CD4
Wolday D; Ndungu FM; Gómez-Pérez GP; de Wit TFR
Front Immunol; 2021; 12():693269. PubMed ID: 34220854
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
4. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.
Del Fresno C; García-Arriaza J; Martínez-Cano S; Heras-Murillo I; Jarit-Cabanillas A; Amores-Iniesta J; Brandi P; Dunphy G; Suay-Corredera C; Pricolo MR; Vicente N; López-Perrote A; Cabezudo S; González-Corpas A; Llorca O; Alegre-Cebollada J; Garaigorta U; Gastaminza P; Esteban M; Sancho D
Front Immunol; 2021; 12():748103. PubMed ID: 34867974
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies.
Rele S
Hum Vaccin Immunother; 2021 Apr; 17(4):1122-1127. PubMed ID: 32993453
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination.
Grimaldi V; Benincasa G; Moccia G; Sansone A; Signoriello G; Napoli C
J Immunol Methods; 2022 Mar; 502():113230. PubMed ID: 35114198
[TBL] [Abstract][Full Text] [Related]
8. The immunology of SARS-CoV-2 infections and vaccines.
Grigoryan L; Pulendran B
Semin Immunol; 2020 Aug; 50():101422. PubMed ID: 33262067
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.
Jung JH; Rha MS; Sa M; Choi HK; Jeon JH; Seok H; Park DW; Park SH; Jeong HW; Choi WS; Shin EC
Nat Commun; 2021 Jun; 12(1):4043. PubMed ID: 34193870
[TBL] [Abstract][Full Text] [Related]
10. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
[TBL] [Abstract][Full Text] [Related]
11. T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: "Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.".
Bsteh G; Sellner J
EBioMedicine; 2021 Dec; 74():103692. PubMed ID: 34773893
[No Abstract] [Full Text] [Related]
12. Rapid and stable mobilization of CD8
Oberhardt V; Luxenburger H; Kemming J; Schulien I; Ciminski K; Giese S; Csernalabics B; Lang-Meli J; Janowska I; Staniek J; Wild K; Basho K; Marinescu MS; Fuchs J; Topfstedt F; Janda A; Sogukpinar O; Hilger H; Stete K; Emmerich F; Bengsch B; Waller CF; Rieg S; Sagar ; Boettler T; Zoldan K; Kochs G; Schwemmle M; Rizzi M; Thimme R; Neumann-Haefelin C; Hofmann M
Nature; 2021 Sep; 597(7875):268-273. PubMed ID: 34320609
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.
Schmidt T; Klemis V; Schub D; Mihm J; Hielscher F; Marx S; Abu-Omar A; Ziegler L; Guckelmus C; Urschel R; Schneitler S; Becker SL; Gärtner BC; Sester U; Sester M
Nat Med; 2021 Sep; 27(9):1530-1535. PubMed ID: 34312554
[TBL] [Abstract][Full Text] [Related]
14. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
Jeong H; Choi YM; Seo H; Kim BJ
Front Immunol; 2021; 12():637654. PubMed ID: 33732258
[TBL] [Abstract][Full Text] [Related]
15. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
16. Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.
Ma Y; Liu F; Lin T; Chen L; Jiang A; Tian G; Nielsen M; Wang M
J Infect Dis; 2021 Sep; 224(6):956-966. PubMed ID: 34145459
[TBL] [Abstract][Full Text] [Related]
17. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.
Ehmsen S; Asmussen A; Jeppesen SS; Nilsson AC; Østerlev S; Vestergaard H; Justesen US; Johansen IS; Frederiksen H; Ditzel HJ
Cancer Cell; 2021 Aug; 39(8):1034-1036. PubMed ID: 34348121
[No Abstract] [Full Text] [Related]
18. COVID vaccine makers brace for a variant worse than Delta.
Waltz E
Nature; 2021 Oct; 598(7882):552-553. PubMed ID: 34671153
[No Abstract] [Full Text] [Related]
19. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine.
Zhang J; He Q; An C; Mao Q; Gao F; Bian L; Wu X; Wang Q; Liu P; Song L; Huo Y; Liu S; Yan X; Yang J; Cui B; Li C; Wang J; Liang Z; Xu M
Emerg Microbes Infect; 2021 Dec; 10(1):1598-1608. PubMed ID: 34278956
[TBL] [Abstract][Full Text] [Related]
20. Repurposing CD8
Gujar S; Pol JG; Kim Y; Kroemer G
Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
